These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4043108)

  • 21. [Ovarian Leydig cell tumor].
    Tönnies P; Mlynek-Kersjes ML; Gellén J; Watermann D
    Zentralbl Gynakol; 1997; 119(5):241-5. PubMed ID: 9281260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virilizing hilus (Leydig) cell tumor of the ovary: the challenge of an accurate preoperative diagnosis.
    Raaf JH; Bajorunas DR; Smith DH; Woodruff J
    Surgery; 1983 Dec; 94(6):951-4. PubMed ID: 6648810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sertoli-Leydig-cell ovarian tumor with a retiform pattern and heterologous elements: a rare cause of virilization].
    García Pascual IJ; Corrales Hernández JJ; Miralles García JM; García Díez LC; Villabona Sánchez V; Serrano de Dios E
    Rev Clin Esp; 1992 Mar; 190(4):191-4. PubMed ID: 1589616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the reliability of 131I-19-iodocholesterol scintigraphic examination in the diagnosis of adrenal tumors].
    Troncone L; Galli G; Focacci C
    Radiol Med; 1980 Nov; 66(11):841-2. PubMed ID: 7221053
    [No Abstract]   [Full Text] [Related]  

  • 27. Scintigraphic localization of ovarian dysfunction.
    Mountz JM; Gross MD; Shapiro B; Barkan AL; Woodbury MC; Schteingart DE; Ayers JW
    J Nucl Med; 1988 Oct; 29(10):1644-50. PubMed ID: 3171694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dissociation between absorption of 131I-19-iodocholesterol and hormonal activity in corticosteroma patients].
    Burliev G; Koev D; Zlatareva N; Khubaveshki S
    Vutr Boles; 1987; 26(3):88-91. PubMed ID: 3617712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature.
    Klotz RK; Müller-Holzner E; Fessler S; Reimer DU; Zervomanolakis I; Seeber B; Mattle V; Wildt L
    Exp Clin Endocrinol Diabetes; 2010 May; 118(5):291-7. PubMed ID: 20198556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sertoli-Leydig tumors in children. 2 case reports].
    Mariani R; Taleb-Figueroa A; Bastiani-Griffet F; Monpoux F; Coussement A; Loubière R
    Ann Pediatr (Paris); 1993 Sep; 40(7):438-43. PubMed ID: 8239395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sonographic characteristics of ovarian Leydig cell tumor.
    Bruno M; Capanna G; Di Florio C; Sollima L; Guido M; Ludovisi M
    Ultrasound Obstet Gynecol; 2023 Sep; 62(3):441-442. PubMed ID: 37021749
    [No Abstract]   [Full Text] [Related]  

  • 32. Ovarian hilus-cell tumours: their varying presentations.
    Salm R
    J Pathol; 1974 Jun; 113(2):117-27. PubMed ID: 4371065
    [No Abstract]   [Full Text] [Related]  

  • 33. Bilateral stromal Leydig cell tumour of the ovary. Case report and literature review.
    Böhm J; Röder-Weber M; Höfler H; Kolben M
    Pathol Res Pract; 1991 Mar; 187(2-3):348-52; discussion 352-3. PubMed ID: 2068019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
    Yetkin DO; Demirsoy ET; Kadioglu P
    Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
    Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
    Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Leydig cell tumor of the ovary (biologic (in vivo and in vitro) and ultrastructural study) (author's transl)].
    Roger P; Mauriac L; Kern AM; Schmitt B; Saurel J; Brun G
    Ann Endocrinol (Paris); 1979; 40(6):571-2. PubMed ID: 547880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ovarian Leydig cell tumor of stromal localization].
    Hadjadj S; Maury F; Leclère J
    Ann Endocrinol (Paris); 1998 Jul; 59(2):125-9; discussion 130-1. PubMed ID: 9789597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virilization with diffuse involvement of ovarian androgen secreting cells.
    Katz M; Hamilton SM; Albertyn L; Pimstone BL; Cohen BL; Tiltman AJ
    Obstet Gynecol; 1977 Nov; 50(5):623-7. PubMed ID: 909673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virilizing Hilus Cell Tumor of the Ovary Associated With Efferent Ductules-like Metaplasia Within Paratubal Mesonephric Remnants.
    Wachter DL; Burghaus S; Beckmann MW; Agaimy A
    Int J Gynecol Pathol; 2016 Jul; 35(4):369-71. PubMed ID: 26630230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.